Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Twist Bioscience Corp

TWST ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Mid Cap Analyst: BUY

Last Close

$118.57

▼ -5.36%

Market Cap $7.86B · Vol 332.09K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$7.86B

Mid Cap

Div Yield

N/A

EPS Growth

-16.91%

YoY

RSI (14)

72.80

Momentum

Beta

2.21

vs Market

52W High

$126.24

6.08% below

52W Low

$23.50

404.55% above

Volume

332.09K

Avg 502.48K

P/B

3.61

Price-to-book

ROE

-16.42%

Return on equity

Free Float

98.62%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Twist Bioscience Corp (TWST) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TWST pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+2.51%

+28.14%

+123.93%

+141.44%

YTD

+273.80%

+311.13%

+455.10%

+17.97%

Financials & Valuation

TTM · Annual

Total Revenue	$376.57M
Net Income	$-77,670,000.00
Revenue Growth (YoY)	+23.24%
Gross Margin	50.72%
Operating Margin	-36.18%
Net Profit Margin	-20.63%
ROE	-16.42%
ROA · ROIC	-12.25% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	4.47
P/B	3.61
P/FCF	N/A
EPS Growth	-16.91%
Outstanding Shares	66.27M

Technical Indicators

50-Day SMA	$93.69
200-Day SMA	$56.78
RSI (14)	72.80
Beta	2.21
52-Week High	$126.24
52-Week Low	$23.50

Volume Today	332.09K
Avg Daily Volume (30D)	502.48K
Relative Volume	0.66x
Volatility (10D)	100.15
Volatility (30D)	82.83
Free Float	98.62%

Analyst Consensus

BUY

Current Price $118.57

Mean Target $111.89

52W Low$23.50 52W High$126.24

Current

Target

$23.50 $126.24

Current Analyst target

-5.63% downside risk · 10 analysts

Identifiers

ExchangeNasdaq

FIGIBBG006KDCHK2

ISINUS90184D1000

CountryUnited States of America

Sub-IndustryBiopharmaceuticals

Earnings DateNov 12, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

REGN Regeneron Pharmaceuticals Inc -0.31% 207940.KS Samsung Biologics Co Ltd -1.02% UCB.BR Ucb SA -3.10% CSL.AX CSL Ltd -0.74% BIIB Biogen Inc -0.39%

Company Profile

Twist Bioscience Corporation provides customizable solutions across the biological continuum that enable scientific discovery and development across therapeutics, diagnostics, and other high-growth markets. The Company's proprietary silicon-based platform delivers precision, scale, and speed, supporting consistent, high-quality performance across a range of applications. The Company’s platform is a differentiated method of manufacturing synthetic deoxyribonucleic acid (DNA) by writing DNA on a silicon chip. By integrating proprietary hardware, software, and scalable infrastructure, including its e-commerce platform. The Company has extended this platform beyond DNA synthesis to offer an integrated portfolio that includes synthetic genes, next-generation sequencing, applications, sample preparation tools, antibody libraries, and biologic discovery services. Leveraging the same platform, it also manufactures synthetic ribonucleic acid (RNA) and expresses antibody proteins.